Recombinant Borrelia hermsii tRNA pseudouridine synthase A (truA)

What is the primary function of tRNA pseudouridine synthase A in B. hermsii?

tRNA pseudouridine synthase A (truA) in B. hermsii likely functions similarly to other bacterial pseudouridine synthases, catalyzing the isomerization of uridine to pseudouridine at specific positions in tRNA molecules. Based on comparative analysis with other pseudouridine synthases like TruB1, this enzymatic activity modifies RNA structure by enhancing base-to-base stacking, which affects RNA stability and function . In the context of B. hermsii, a relapsing fever agent, these RNA modifications likely play important roles in pathogen survival and potentially virulence mechanisms during infection cycles.

How does truA differ structurally and functionally from other pseudouridine synthases found in Borrelia species?

While the search results don't provide direct structural comparisons of truA with other pseudouridine synthases in Borrelia, we can infer from studies of TruB1 that different pseudouridine synthases target distinct positions within RNA substrates. TruB1 introduces pseudouridine specifically at position 55 of tRNAs , whereas truA likely targets different positions. The functional differences would stem from distinct RNA recognition domains and catalytic sites tailored to specific substrate interactions. Similar to how B. hermsii proteins like FhbA show antigenic specificity , truA likely possesses species-specific structural features that distinguish it from homologs in other Borrelia species.

What expression systems are most effective for producing recombinant B. hermsii truA?

For recombinant expression of B. hermsii proteins, E. coli-based expression systems utilizing vectors such as pET32-Ek/LIC have proven effective. Based on protocols for other B. hermsii proteins, gene amplification using PCR with primers containing appropriate vector-compatible extensions, followed by T4 DNA polymerase treatment to generate single-stranded overhangs, allows efficient annealing into expression vectors . For optimal expression, incorporating N-terminal tags (such as S and His tags) can facilitate both expression monitoring and subsequent purification steps. Expression conditions would need optimization regarding temperature, IPTG concentration, and induction timing to maximize soluble protein yield.

What are the recommended methods for validating the enzymatic activity of recombinant truA?

For validating truA enzymatic activity, an in vitro enzyme assay using appropriate tRNA substrates would be the gold standard. Based on methods used for TruB1, activity can be assessed by monitoring pseudouridine formation in substrate RNAs . The presence of pseudouridine can be detected through chemical approaches such as CMC (N-cyclohexyl-N′-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate) treatment followed by primer extension assay, where reverse transcriptase stops at CMC-modified pseudouridine sites . Comparing wild-type enzyme activity with carefully designed catalytically inactive mutants (similar to the TruB1 mt1 mutant approach) provides essential controls for validating specific enzymatic activity .

How can site-directed mutagenesis be applied to dissect the catalytic mechanism of B. hermsii truA?

Site-directed mutagenesis represents a powerful approach for investigating truA's catalytic mechanism. Based on studies with TruB1, researchers should target conserved amino acid residues involved in:

• Enzymatic activity (analogous to D48, D90 in TruB)

• RNA-binding capability (similar to K64 in TruB)

By generating specific mutants (catalytically inactive but RNA-binding capable, and RNA-binding deficient variants), researchers can separate the contributions of substrate binding from enzymatic activity. Each mutant should be characterized through:

• In vitro enzymatic activity assays with tRNA substrates

• RNA binding assessment via EMSA (Electrophoretic Mobility Shift Assay)

• Structural analysis to confirm proper protein folding

This approach would reveal whether truA, like TruB1, might possess RNA chaperone functions independent of its pseudouridylation activity.

What high-throughput methods are suitable for identifying the complete substrate range of B. hermsii truA?

To comprehensively identify truA substrates, researchers should employ HITS-CLIP (High-Throughput Sequencing Cross-Linking Immunoprecipitation) or similar techniques that capture RNA-protein interactions in vivo. This approach, successfully used with TruB1 , involves:

• Cross-linking truA to its RNA substrates within B. hermsii cells

• Immunoprecipitation of truA-RNA complexes

• RNA extraction, library preparation, and high-throughput sequencing

• Bioinformatic analysis to identify enriched RNA sequences and structures

These methods would reveal whether truA, like some other pseudouridine synthases, has unexpected RNA targets beyond canonical tRNAs, potentially including mRNAs or regulatory RNAs that might influence B. hermsii gene expression and pathogenesis.

How conserved is truA across different Borrelia species and what does this suggest about its evolutionary significance?

While the search results don't directly address truA conservation, we can draw parallels with other Borrelia proteins. Similar to BipA, which is "specific to TBRF Borrelia but heterogenic between species" , truA likely shows both conserved functional domains and species-specific variations. Researchers should perform comprehensive sequence alignments of truA across multiple Borrelia species to identify:

• Highly conserved catalytic domains essential for function

• Variable regions that might contribute to species-specific activities

• Evidence of selective pressure that might indicate host adaptation

Such analysis would provide insight into whether truA plays roles in species-specific adaptations of different Borrelia pathogens to their respective hosts and vectors.

Can phylogenetic analysis of truA sequences help discriminate between closely related Borrelia species?

Given that proteins like BipA show species-specific variations that enable discrimination between North American TBRF Borrelia infections , similar analysis of truA sequences might prove valuable for taxonomic and diagnostic purposes. Researchers should investigate whether truA sequences contain sufficient variability between species like B. hermsii, B. turicatae, and B. parkeri to serve as phylogenetic markers. Such analysis requires:

• Amplification and sequencing of truA from multiple isolates of each species

• Detailed sequence and structural comparisons

• Evaluation of whether variations correlate with established phylogenetic relationships

• Assessment of whether these differences could provide diagnostic specificity

This approach could contribute to improved molecular typing of Borrelia species, enhancing both taxonomic understanding and diagnostic capabilities.

How does the expression of truA vary during different stages of B. hermsii infection and relapse cycles?

Understanding truA expression patterns during infection cycles would provide insight into its potential role in pathogenesis. Given that B. hermsii undergoes antigenic variation through recombination during relapsing fever cycles , researchers should investigate whether truA expression correlates with these cycles. Methods to address this question include:

• qRT-PCR analysis of truA transcription during different infection phases

• Western blot analysis of truA protein levels in B. hermsii isolated from different relapse populations

• Reporter gene fusions to monitor truA promoter activity during infection

• RNA-seq analysis comparing truA expression across different serotypes and relapse populations

Such studies would reveal whether truA activity is constitutive or regulated in response to host environments or relapse cycles.

Does B. hermsii truA contribute to immune evasion mechanisms during infection?

This advanced question requires experimental investigation of potential interactions between truA and host immunity. Based on knowledge that some B. hermsii proteins like FhbA are antigenic during infection , researchers should assess:

• Whether truA elicits antibody responses during infection in animal models

• If truA-mediated RNA modifications influence expression of surface antigens involved in immune evasion

• Whether truA activity differs between infectious and non-infectious B. hermsii forms

• If truA mutations affect the relapsing fever pattern in experimental infections

These investigations would help determine whether truA represents a potential therapeutic target for disrupting B. hermsii persistence mechanisms.

What strategies can overcome expression and solubility challenges when working with recombinant B. hermsii truA?

Recombinant expression of functional B. hermsii proteins can present technical challenges. Based on approaches used for other Borrelia proteins, researchers facing truA expression difficulties should consider:

The optimal approach likely combines several strategies, with systematic comparison of protein yield, solubility, and enzymatic activity to determine the most effective production method .

What experimental designs are most appropriate for investigating potential moonlighting functions of B. hermsii truA?

To investigate whether truA possesses functions beyond canonical tRNA modification (moonlighting functions), researchers should employ experimental designs that distinguish enzymatic activity from other protein functions. Based on studies of TruB1, which showed enzyme activity-independent functions , appropriate approaches include:

• Comparative phenotyping: Create B. hermsii strains expressing:

  • Wild-type truA

  • Catalytically inactive truA (point mutations in active site)

  • truA knockout

• Protein-protein interaction studies:

  • Pull-down assays with recombinant truA

  • Bacterial two-hybrid screening

  • Co-immunoprecipitation followed by mass spectrometry

• Functional complementation:

  • Testing whether catalytically inactive truA can complement phenotypes in truA knockout strains

• Heterologous expression impacts:

  • Expressing B. hermsii truA in model organisms to identify non-canonical effects

This multi-faceted approach would effectively distinguish between pseudouridylation-dependent and independent functions of truA .

How should researchers interpret contradictory results between in vitro and in vivo studies of B. hermsii truA function?

Researchers encountering discrepancies between in vitro truA enzymatic assays and in vivo functional studies should implement a systematic approach to reconcile the findings. Based on experimental design principles from implementation science :

• Verify experimental conditions: Ensure in vitro conditions appropriately mimic physiological context (pH, ion concentrations, potential cofactors)

• Examine temporal dynamics: In vivo systems may exhibit time-dependent effects not captured in vitro

• Consider experimental design limitations:

  • For in vitro studies: substrate accessibility, protein modifications, interacting partners

  • For in vivo studies: potential compensatory mechanisms, indirect effects

• Implement validation steps:

  • Use multiple complementary methodologies

  • Perform dose-response relationships

  • Include appropriate positive and negative controls

  • Test across different strains/isolates of B. hermsii

• Apply quasi-experimental designs: When randomized controlled trials aren't feasible, consider interrupted time series or stepped wedge designs to strengthen causal inferences

Systematic application of these principles will help distinguish true biological complexity from experimental artifacts.

What statistical approaches are most appropriate for analyzing truA pseudouridylation activity across different B. hermsii strains?

When analyzing pseudouridylation activity across multiple B. hermsii strains or isolates, researchers should employ robust statistical approaches that account for biological variability. Based on experimental design principles :

• Sample size determination:

  • Power analysis to determine minimum required replicates

  • Account for anticipated effect sizes between strains

• Appropriate statistical tests:

  • One-way ANOVA with post-hoc tests for multiple strain comparisons

  • Mixed-effects models for repeated measurements

  • Non-parametric alternatives when normality assumptions aren't met

• Control for confounding variables:

  • Growth phase standardization

  • RNA substrate batch effects

  • Environmental conditions during growth

• Data visualization approaches:

  • Box plots showing distribution of activity measurements

  • Forest plots for meta-analysis across experiments

  • Heat maps for substrate specificity patterns

• Correction for multiple comparisons:

  • Bonferroni correction for stringent control

  • False Discovery Rate methods for exploratory analyses

How might understanding B. hermsii truA function contribute to improved diagnostic methods for tick-borne relapsing fever?

Given the challenges in diagnosing tick-borne relapsing fever (TBRF) and distinguishing between causative Borrelia species, truA research could potentially contribute to improved diagnostics. Similar to BipA, which shows promise as a species-specific diagnostic antigen , truA or its unique pseudouridylated RNA products might serve as biomarkers. Researchers should investigate:

• Whether truA protein elicits specific antibody responses during B. hermsii infection

• If these antibody responses can distinguish B. hermsii from other TBRF Borrelia species

• Whether unique truA-modified tRNAs or their fragments appear in host circulation during active infection

• If recombinant truA can be utilized in serological assays similar to those developed for BipA

This research direction could address the current limitations in TBRF diagnostics, which "is likely underdiagnosed or misdiagnosed as Lyme disease due to poorly developed diagnostic tests" .

What implications does truA research have for understanding B. hermsii adaptation to different host environments?

Research into truA function may provide insight into how B. hermsii adapts to diverse environments during its complex life cycle. Researchers should investigate whether truA-mediated RNA modifications contribute to translational regulation that facilitates adaptation between tick vectors and mammalian hosts. Key research directions include:

• Comparative analysis of truA activity and tRNA modification patterns between B. hermsii grown under conditions mimicking tick versus mammalian environments

• Investigation of whether truA activity influences the efficiency of translation of specific genes important for host adaptation

• Analysis of whether truA mutations affect the ability of B. hermsii to transition between hosts or establish infection

• Examination of whether temperature shifts (tick to mammal transition) alter truA substrate specificity or activity